Novartis Gets Phase 3-Ready Rare Kidney Disease Drug via $800M Regulus Acquisition
Novartis has made kidney disorders an area of focus, and it’s now adding a new drug prospect through a deal ...
Novartis has made kidney disorders an area of focus, and it’s now adding a new drug prospect through a deal ...
Sanofi and Regeneron Pharmaceuticals drug Dupixent has won FDA approval for chronic spontaneous urticaria, introducing a new approach to the ...
The next wave of metabolic medicines in development includes oral GLP-1 drugs that work comparably to currently available injectable medicines, ...
An experimental Alzheimer’s disease therapy designed by Alzheon to reduce depositions of amyloid plaque in the brain failed to beat ...
FREETOWN, Sierra Leone (AP) — At a vast landfill in Sierra Leone 's capital of Freetown, smoke billows over decades ...
By MIKE MAGEE Question: What is the world’s most widely used psychoactive drug? Answer: Caffeine In the U.S., caffeine is ...
Novo Nordisk has been on the hunt for differentiated obesity drugs that could complement its blockbuster GLP-1 agonist, Wegovy. It’s ...
For the first time, traditional drug spending has exceeded specialty drug spending, largely due to the demand for GLP-1s, according ...
Brain cancers are notoriously difficult to treat, with surgery and radiation continuing to be the main options for these malignancies. ...
(Note: Thank you for supporting businesses like the one presenting a sponsored message below and working with them through the ...
Copyright © 2024 EuroAsia24 News.
EuroAsia24 News is not responsible for the content of external sites.